Phase 2 study

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting

Phase Phase 2

Sponsor Bristol-Myers Squibb

Registry number NCT03899155

Started 9 August 2019 Today 16 October 2026 Estimated completion 25 August 2029

Where this trial is running

Trial sites and the status recorded for each
Site	City	State or country	Status at this site
Local Institution - 0045	Coffs Harbour	NSW	Completed
Melanoma Institute Australia	North Sydney	NSW	Recruiting
Local Institution - 0009	Sydney	NSW	Completed
Local Institution - 0193	Waratah	NSW	Completed
Local Institution - 0208	Westmead	NSW	Completed
Gallipoli Medical Foundation	Greenslopes	QLD	Recruiting
Local Institution - 0372	Greenslopes	QLD	Withdrawn
Local Institution	South Brisbane	QLD	Withdrawn
Tasman Oncology Research Ltd	Southport	QLD	Recruiting
Local Institution	Adelaide	SA	Withdrawn
Local Institution - 0196	Elizabeth Vale	SA	Completed
BRICC - Ballarat Health Services	Ballarat	VIC	Recruiting
Local Institution - 0365	Fitzroy	VIC	Completed
Cabrini Hospital Malvern	Malvern	VIC	Recruiting
Local Institution - 0174	Murdoch	WA	Withdrawn

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over

Sex Anyone, regardless of sex

Healthy volunteers Not accepted

Enrolment target 1500

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria

* Signed Written Informed Consent.

* Eligible to receive continued study treatment per the Parent Study, including treatment beyond progression per investigator assessment in the Parent Study.

* On treatment hold in the Parent Study following long-lasting response or are eligible for treatment rechallenge as defined in the Parent Study.

* WOCBP and male participants who are sexually active must agree to follow instructions for method(s) of contraception as described below and included in the ICF.

Exclusion Criteria

* Participant is not eligible for study treatment per the Parent Study eligibility criteria.

* Participants not receiving clinical benefit as assessed by the Investigator.

* Any clinical adverse event (AE), laboratory abnormality, or intercurrent illness which, in the opinion of the Investigator, indicates that participation in the study is not in the best interest of the participant.

* Other protocol-defined Inclusion/Exclusion Criteria apply

Dates on the record

Started 9 August 2019

Estimated completion 25 August 2029

Registry last updated 23 September 2026

Checked by Voxsanity 11 October 2026

Results, publications and the official record

No results are posted on the official record yet.
No publications are listed on the official record yet.
Official record and contacts on ClinicalTrials.gov – contact details for each site are kept there, and are not copied onto this page.

Sources and dates

ClinicalTrials.gov – the record this page reformats
ClinicalTrials.gov processing date: 23 September 2026.
This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.

Voxsanity

Clinical trials recruiting in Australia, from the public registries · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial, which may be relevant to my care:

Trial: NCT03899155

Sponsor: Bristol-Myers Squibb

Phase: Phase 2

Status: Recruiting

More information: https://clinicaltrials.gov/study/NCT03899155

Eligibility criteria, as the registry published them

Reproduced exactly, unedited. Written for researchers rather than for patients.

Inclusion Criteria

Signed Written Informed Consent.
Eligible to receive continued study treatment per the Parent Study, including treatment beyond progression per investigator assessment in the Parent Study.
On treatment hold in the Parent Study following long-lasting response or are eligible for treatment rechallenge as defined in the Parent Study.
WOCBP and male participants who are sexually active must agree to follow instructions for method(s) of contraception as described below and included in the ICF.

Exclusion Criteria

Participant is not eligible for study treatment per the Parent Study eligibility criteria.
Participants not receiving clinical benefit as assessed by the Investigator.
Any clinical adverse event (AE), laboratory abnormality, or intercurrent illness which, in the opinion of the Investigator, indicates that participation in the study is not in the best interest of the participant.
Other protocol-defined Inclusion/Exclusion Criteria apply

A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a registered health practitioner to access unapproved therapeutic goods for individual patients.

Not medical advice. Voxsanity reformats information published by public registries. It does not give medical advice and is not a substitute for talking to your doctor.